Naomi Kresge

Stay informed with Naomi Kresge’s coverage and analysis for Fortune.

Page 3 of 4

  • A vial of the Pfizer-BioNTech Covid-19 vaccine at a vaccination site in Montevideo, Uruguay, on Monday, Aug. 16, 2021. Uruguay will give Pfizer Inc. booster shots to people who have already received two doses of the less-effective Sinovac Biotech Ltd. vaccine, to increase the populations immunity to Covid-19 variants such as delta. Photographer: Ana Ferreira/Bloomberg via Getty ImagesHealth

    A U.K. study finds that Pfizer’s vaccine is less effective against Delta 90 days after full vaccination

    By Naomi Kresge and Bloomberg
  • Children wearing facemasks during a lesson at Outwood Academy in Woodlands, Doncaster in Yorkshire, as pupils in England return to school for the first time in two months as part of the first stage of lockdown easing. Picture date: Monday March 8, 2021. (Photo by Danny Lawson/PA Images via Getty Images)Health

    Children with COVID usually recover within a week, according to a U.K. study

    By Naomi Kresge and Bloomberg
  • 12 January 2021, Rhineland-Palatinate, Mainz: The logo and lettering of the Biontech company is on the façade of a new building in an industrial park in Mainz that is not yet completely finished. The Corona vaccine from Biontech and its US partner Pfizer is currently in high demand worldwide. Photo: Boris Roessler/dpa (Photo by Boris Roessler/picture alliance via Getty Images)Health

    BioNTech plans on developing a vaccine that prevents Malaria

    By Naomi Kresge and Bloomberg
  • IRELAND – 2021/02/07: In this photo illustration a silhouette of a man holding a medical syringe and a vial seen displayed in front of the CureVac logo on a screen. (Photo Illustration by Cezary Kowalski/SOPA Images/LightRocket via Getty Images)International

    Shares in Musk-promoted CureVac plunge after vaccine study shows only 47% efficacy

    By Naomi Kresge and Bloomberg
  • A picture taken on April 12, 2021 shows a phial of Johnson & Johnson Janssen Covid-19 vaccine as the first doses proceeding from the Dutch city of Leiden are stored at the Movianto distribution center in Oss. – Johnson & Johnson Janssen Covid-19 vaccine is the fourth corona vaccine that will become available in the Netherlands. – Netherlands OUT (Photo by ROB ENGELAAR / ANP / AFP) / Netherlands OUT (Photo by ROB ENGELAAR/ANP/AFP via Getty Images)Health

    Johnson & Johnson to delay Europe vaccine rollout amid U.S. pause over six blood clot cases

    By Marthe Fourcade, Naomi Kresge, and others
  • An Israeli health worker of the Maccabi Healthcare Services prepares to administer a dose of the Pfizer-BioNtech vaccine on February 24, 2021 in Tel Aviv. (Photo by JACK GUEZ / AFP) (Photo by JACK GUEZ/AFP via Getty Images)Health

    After just one dose of the Pfizer-BioNTech vaccine, hospitalizations are down 92%, Israeli study shows

    By Naomi Kresge, Jason Gale, and others
  • 22 January 2021, Baden-Wuerttemberg, Ravensburg: Doctor’s assistant Funda Özagac holds a syringe containing the Biontech/Pfizer vaccine against the coronavirus. The district vaccination centre had opened in the morning in the Oberschwabenhalle. Photo: Felix Kästle/dpa (Photo by Felix Kästle/picture alliance via Getty Images)Health

    WHO reaffirms safety of Pfizer BioNTech vaccine for elderly patients after Norway scare

    By Naomi Kresge and Bloomberg
  • Svein Andersen, 67 years-old resident of ‘Ellingsrud home’ and first in Norway to receive the vaccine is given the Pfizer-Biontech Covid-19 corona virus vaccine by Nurse Maria Golding in Oslo, Norway, on December 27, 2020. – The European Union began a vaccine rollout, even as countries in the bloc were forced back into lockdown by a new strain of the virus, believed to be more infectious, that continues to spread from Britain. The pandemic has claimed more than 1.7 million lives and is still running rampant in much of the world, but the recent launching of innoculation campaigns has boosted hopes that 2021 could bring a respite. (Photo by Fredrik Hagen / NTB / AFP) / Norway OUT (Photo by FREDRIK HAGEN/NTB/AFP via Getty Images)Health

    Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn

    By Lars Erik Taraldsen, Naomi Kresge, and others
  • NIJMEGEN, NETHERLANDS – JANUARY 2: Corona vaccine / Covid-19 vaccine illustration. Vial being held by a hand in blue gloves in front of Moderna logo on January 2, 2021 in Nijmegen, Netherlands (Photo by John Beckmann/BSR Agency/Getty Images)Health

    EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations

    By Naomi Kresge and Bloomberg
  • 04 January 2021, Saxony, Dresden: Anke Döring, internist at the Städtisches Klinikum Dresden, holds an injection vial with the Corona vaccine in the vaccination center for employees. On Monday, Corona vaccinations with the Biontech/Pfizer vaccine began at the Municipal Hospital for medical staff in the high-risk areas and Covid 19 wards. Photo: Robert Michael/dpa-Zentralbild/dpa (Photo by Robert Michael/picture alliance via Getty Images)Health

    EU seeks an additional 300 million Pfizer-BioNTech vaccine doses

    By Naomi Kresge, John Follain, and others
  • 22 December 2020, Hessen, Mainz: Ugur Sahin, co-founder and CEO of Biontech, stands on the company premises. Biontech is a biotechnology company that is researching, among other things, vaccines against the corona virus. The EU Commission recently granted conditional marketing authorisation to the Corona vaccine produced by Biontech and its US partner Pfizer. Photo: Andreas Arnold/dpa (Photo by Andreas Arnold/picture alliance via Getty Images)Health

    BioNTech CEO says its joint vaccine with Pfizer will likely work on new U.K. virus variant

    By Naomi Kresge and Bloomberg
  • A staff nurse at the Royal Cornwall Hospital prepares to administer Covid-19 vaccinations as the hospital began their vaccination programme on December 9, 2020 in Truro, United Kingdom. More than 50 hospitals across England were designated as covid-19 vaccine hubs, the first stage of what will be a lengthy vaccination campaign. NHS staff, over-80s, and care home residents will be among the first to receive the Pfizer/BioNTech vaccine, which recently received emergency approval from the country’s health authorities. (Photo by Hugh Hastings/Getty Images)Health

    U.K. warns people with history of severe allergic reactions not to get the COVID-19 vaccine

    By Naomi Kresge, Emily Ashton, and others
  • US-HEALTH-MODERNAInternational

    Moderna has never distributed a product before. A Swiss company is here to help

    By Naomi Kresge and Bloomberg
  • The logo of German payments provider Wirecard is seen at a building of the company’s headquarters in Aschheim near Munich, southern Germany, on September 2, 2020. – Germany is poised to launch a full parliamentary inquiry into the collapse of payments provider Wirecard, as questions mount on how the government failed to prevent the country’s biggest post-war financial scandal. After grilling members of Chancellor Angela Merkel’s cabinet behind closed doors, opposition lawmakers on parliament’s finance committee said they have no choice but to up the ante and seek a full inquiry. (Photo by Christof STACHE / AFP) (Photo by CHRISTOF STACHE/AFP via Getty Images)Finance

    Santander buys assets from Wirecard, as failed payments company is wound down

    By Naomi Kresge and Bloomberg
  • ANKARA, TURKEY – OCTOBER 27: Injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus (COVID-19) pandemic by the U.S. Pfizer and German BioNTech company, are seen at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. This vaccine candidate, within the scope of phase 3 studies, was injected to volunteers in Ankara University Ibni Sina Hospital. (Photo by Dogukan Keskinkilic/Anadolu Agency via Getty Images)Health

    Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections

    By Robert Langreth, Naomi Kresge, and others